ワクチン政策のための科学: 2025年12月のACIP会議での透明性の欠如,誤った情報,そして不適切な意思決定プロセス

Jamie Loehr¹, Charlotte A Moser², Edwin J Asturias³

¹Cayuga Family Medicine, Ithaca, NY, USA.

Vaccine

|February 20, 2026

まとめ

米国のワクチン政策は,慎重に検討されている. 予防接種慣行に関する諮問委員会

科学分野:

公衆衛生は公衆衛生である.
予防接種政策について
エピデミオロジーエピデミオロジー

背景:

再興する感染症は,緊急にワクチン政策の評価を必要とします.
予防接種慣行諮問委員会 (ACIP) は,米国のワクチン政策制定において重要な役割を果たしています.
ACIPの会議の分析は,ワクチン政策立案の健全性を理解する上で極めて重要です.

研究の目的:

ACIPの2025年12月の会合を包括的に分析する.
ACIPの審議の透明性と質を評価する.
ACIPのワクチン推奨の根拠と根拠を評価する.

主な方法:

会議前の公衆のコメントのテーマ分析.
メンバーの交換前と後のACIP会議の透明性の体系的な比較.
会議のトピックの特徴,コメントの正確性,B型肝炎ワクチンの投票のための証拠.

主要な成果:

2025年12月のACIP会議は,透明度が低く (53%のスコア),通常よりも少ないトピックが取り上げられました.
ACIPメンバーのプレゼンテーションとコメントには,ワクチンの安全性と有効性に関する誤った情報の60以上の事例が含まれています.
B型肝炎ワクチンの出産用量を削除する勧告は,潜在的に感染率を増やす可能性のある,支持する証拠が欠けていた.

結論:

ACIPの審議の質は低下しています.
ACIPの政策勧告は,特にB型肝炎ワクチンに関して,公衆衛生に潜在的に有害である.
ACIPの会議の透明性,証拠に基づいた意思決定,および正確性を向上させるには,重大な必要性があります.

キーワード:

出産時の用量出産時の用量 B型肝炎 (B型肝炎) について小児科の小児科プライマリーケアプライマリーケアセキュリティーセキュリティーセキュリティーセキュリティーワクチン接種ワクチン接種

さらに関連する動画

13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.9K

08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.3K

関連する概念動画

Vaccinations

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...

01:26

Principles of Disease Surveillance

610

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...

610

01:29

Bias in Epidemiological Studies

1.4K

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:

1.4K

01:30

Cancer Vaccines

1.1K

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

1.1K

01:22

Healthcare Associated Infections II: Preventive Measures

4.4K

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...